Emily Ko
About
In The Last Decade
Emily Ko
172 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Obstetrics and Gynecology 815
- Reproductive Medicine 798
- Oncology 669
- Surgery 428
- Epidemiology 287
Countries citing papers authored by Emily Ko
This map shows the geographic impact of Emily Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Ko more than expected).
Fields of papers citing papers by Emily Ko
This network shows the impact of papers produced by Emily Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Ko. The network helps show where Emily Ko may publish in the future.
Co-authorship network of co-authors of Emily Ko
This figure shows the co-authorship network connecting the top 25 collaborators of Emily Ko. A scholar is included among the top collaborators of Emily Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Ko. Emily Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 13 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 5 | |
| 13 | 11 | |
| 14 | Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study breakdown → | 224 |
| 15 | 2 | |
| 16 | 7 | |
| 17 | 9 | |
| 18 | 46 | |
| 19 | 11 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.